1-20 of 131
Leah Lawrence
Close
Sort by
News

miRNA Identified as Potential ITP Diagnostic Biomarker

Leah Lawrence
Published: 2025
Abstract
April 2025
View News titled, miRNA Identified as Potential ITP Diagnostic Biomarker
News

Post-Transplant Mutation Clearance Important Indicator of Prognosis for Myelofibrosis

Leah Lawrence
Published: 2025
Abstract
April 2025
View News titled, Post-Transplant Mutation Clearance Important Indicator of Prognosis for Myelofibrosis
News

Now Enrolling: Vulnerable Populations

Leah Lawrence
Published: 2025
Abstract
April 2025 Updates to the Declaration of Helsinki encourage researchers to include people who previously were excluded from clinical trials.
View News titled, Now Enrolling: Vulnerable Populations
News

AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia

Leah Lawrence
Published: 2025
Abstract
March 2025
View News titled, AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia
News

Long-Term Survivors of Multiple Myeloma Have Persistent Immune Alterations

Leah Lawrence
Published: 2025
Abstract
March 2025
View News titled, Long-Term Survivors of Multiple Myeloma Have Persistent Immune Alterations
News

MRD Status Important Prognostic Factor for R/R MM Treated With T-Cell Redirecting Therapies

Leah Lawrence
Published: 2025
Abstract
February 2025
View News titled, MRD Status Important Prognostic Factor for R/R MM Treated With T-Cell Redirecting Therapies
News

IL-1β Inhibitor Canakinumab May Be Effective in Specific Genetic Subsets of Lower-Risk MDS

Leah Lawrence
Published: 2025
Abstract
February 2025
View News titled, IL-1β Inhibitor Canakinumab May Be Effective in Specific Genetic Subsets of Lower-Risk MDS
News

Health Care Handcuffed?

Leah Lawrence
Published: 2024
Abstract
January 2025 The overturning of the Chevron doctrine, a decades-old precedent, opens the door to legal challenges affecting health care agencies and, ultimately, patient care.
View News titled, Health Care Handcuffed?
News

BOVen Regimen NCCN-Approved Option for TP53-Mutated MCL

Leah Lawrence
Published: 2024
Abstract
December 2024
View News titled, BOVen Regimen NCCN-Approved Option for TP53-Mutated MCL
News

Geriatric Assessment-Guided Conditioning Reduced Non-Relapse Mortality for Transplant in Myeloid Malignancies

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, Geriatric Assessment-Guided Conditioning Reduced Non-Relapse Mortality for Transplant in Myeloid Malignancies
News

p53 May Have Role in VEXAS Syndrome

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, p53 May Have Role in VEXAS Syndrome
News

Addition of Induction Gilteritinib May Provide Some Benefit for Newly Diagnosed FLT3-Mutated AML

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, Addition of Induction Gilteritinib May Provide Some Benefit for Newly Diagnosed FLT3-Mutated AML
News

BOREAS: MDM2 Inhibitor Treats R/R Myelofibrosis Better Than Best Available Therapy

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, BOREAS: MDM2 Inhibitor Treats R/R Myelofibrosis Better Than Best Available Therapy
News

BCMA/CD19 Dual-Targeting CAR T-Cell Therapy Shows Promising Efficacy in R/R MM

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, BCMA/CD19 Dual-Targeting CAR T-Cell Therapy Shows Promising Efficacy in R/R MM
News

Diet-Derived Metabolite Affects CAR T-Cell Treatment in Mouse Models

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, Diet-Derived Metabolite Affects CAR T-Cell Treatment in Mouse Models
News

Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?

Leah Lawrence
Published: 2024
Abstract
December 2024
View News titled, Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?
News

CHIP-Driver Genes Confer Variable Risk for Progression to Therapy-Related Myeloid Neoplasms

Leah Lawrence
Published: 2024
Abstract
Mid-November 2024
View News titled, CHIP-Driver Genes Confer Variable Risk for Progression to Therapy-Related Myeloid Neoplasms
News

CLL Precursor Condition Linked with Melanoma Risk

Leah Lawrence
Published: 2024
Abstract
Mid-November 2024
View News titled, CLL Precursor Condition Linked with Melanoma Risk
News

When Treatment Includes Substance Use Disorders

Leah Lawrence
Published: 2024
Abstract
November 2024 A patient’s substance use disorder can complicate treatment for a hematologic condition, but physicians must view the comorbidity as an opportunity to provide support.
View News titled, When Treatment Includes Substance Use Disorders
News

Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?

Leah Lawrence
Published: 2024
Abstract
October 2024
View News titled, Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?